2021 연구자 정보 (14 / 1141)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Fang, Xuekun (Fang, XK) |
Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou, Peoples R China MIT, Ctr Global Change Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA |
L-1630-2015 FANG, XUEKUN |
|
[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
Luke.western@bristol.ac.uk rprinn@mit.edu matt.rigby@bristol.ac.uk |
||
|
Ganesan, Anita L. (Ganesan, AL) |
Univ Bristol, Sch Geog Sci, Bristol, Avon, England |
D-6230-2016 Ganesan, Anita |
0000-0001-5715-8923 Ganesan, Anita |
[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
Luke.western@bristol.ac.uk rprinn@mit.edu matt.rigby@bristol.ac.uk |
||
|
Han, Hye Sook (Han, HS) |
제1저자 |
Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Internal Med, Coll Med, Cheongju, South Korea Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Internal Med, Coll Med, Cheongju, Chungcheongbuk, South Korea |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma [JCR상위 32.5%] Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16) [JCR상위 2.2%] Real-world outcomes of second-line ramucirumab plus paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma: A nationwide retrospective study in Korea (KCSG-ST19-16). |
SCIE | 0.7 |
MULTIDISCIPLINARY SCIENCES ONCOLOGY |
twkimmd@amc.seoul.kr shivam@gene.com fhdzang@hallym.or.kr |
|
|
Han, Oakpil (Han, O) |
Hanmi Pharmaceut Co Ltd, Dept Clin Res & Dev, Seoul, South Korea |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
|
Hong, Dongwan (Hong, D) |
Kyungpook Natl Univ, Sch Med, Dept Anat, Daegu, South Korea Catholic Univ Korea, Dept Med Informat, Coll Med, Seoul, South Korea |
GZL-8756-2022 Hong, Dongwan |
|
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
||
|
Hong, Joo Hee (Hong, JH) |
Kyungpook Natl Univ, Sch Med, Dept Anat, Daegu, South Korea |
|
|
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
||
|
Hong, Yong Sang (Hong, YS) |
Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
|
Hong, Yoon-hee (Hong, YH) |
Hanmi Pharmaceut Co Ltd, Dept Clin Res & Dev, Seoul, South Korea |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
|
Hunsaker, Thomas (Hunsaker, T) |
Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
|
Ju, Young Seok (Ju, YS) |
교신저자 |
Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea GENOME INSIGHT Inc, Daejeon, South Korea |
E-1324-2012 Ju, Young Seok |
0000-0002-5514-4189 Ju, Young Seok |
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
|
|
Kim, Ryul (Kim, R) |
제1저자 |
Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea Inha Univ Hosp, Dept Neurol, Incheon, South Korea |
|
0000-0002-8754-9180 Kim, Ryul |
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation [JCR상위 4.0%] Association of Physical Activity and APOE Genotype With Longitudinal Cognitive Change in Early Parkinson Disease [JCR상위 35.6%] Impact of the apolipoprotein E? 4 allele on early Parkinson ? s disease progression [JCR상위 26.7%] Potential Sex-Specific Effects of Apolipoprotein E ε4 on Cognitive Decline in Early Parkinson's Disease |
SCIE | 0.7 |
MULTIDISCIPLINARY SCIENCES CLINICAL NEUROLOGY NEUROSCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr junjs@hallym.or.kr |
|
|
Kim, Su Yeon (Kim, SY) |
Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea |
|
|
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
||
|
Kim, Yu Jung (Kim, YJ) |
Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Hematol & Med Oncol,Coll Med, Seongnam, South Korea |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
|
Klijn, Christiaan (Klijn, C) |
Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
|
Kwon, Seong Gyu (Kwon, SG) |
Kyungpook Natl Univ, Sch Med, Dept Anat, Daegu, South Korea |
|
|
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
페이지 이동: